PUBLISHER: Value Market Research | PRODUCT CODE: 2032759
PUBLISHER: Value Market Research | PRODUCT CODE: 2032759
Global Infectious Diseases Molecular Diagnostics Market Size, Share, Trends & Growth Analysis Report 2026-2034
The global infectious diseases molecular diagnostics market size is expected to reach USD 24.01 Billion in 2034 from USD 17.00 Billion in 2025, growing at a CAGR of 3.91 during 2026-2034.This market is expanding rapidly as the demand for accurate and rapid diagnostic solutions increases in response to global health challenges. Molecular diagnostics technologies, including PCR and next-generation sequencing, are widely used to detect infectious diseases with high precision. The rising incidence of infectious diseases and the need for early detection are major factors driving market growth. Additionally, the increasing adoption of advanced diagnostic tools in healthcare systems is supporting market expansion.
Key drivers include advancements in diagnostic technologies and the growing focus on preventive healthcare. Molecular diagnostics offer faster and more accurate results compared to traditional methods, making them essential in managing infectious diseases. The expansion of healthcare infrastructure and the increasing availability of diagnostic services are also contributing to market growth. Furthermore, government initiatives and funding for disease surveillance and control are supporting the adoption of these technologies.
Future prospects for this market remain highly promising, with continued innovation expected to enhance diagnostic capabilities and accessibility. The development of portable and point-of-care diagnostic devices will expand application areas. Emerging markets are likely to witness significant growth due to improving healthcare systems and awareness. As global health challenges continue to evolve, the infectious diseases molecular diagnostics market is poised for sustained expansion.
Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:
Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.
Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.
Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.
Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.
Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.
Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.
Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.
Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.
MARKET SEGMENTATION
By Product
- Instruments
- Reagents
- Services
By Technology
- Polymerase Chain Reaction (PCR)
- In Situ Hybridization
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Chips and Microarrays
- Mass Spectrometry
- Transcription Mediated Amplification
- Others
By Application
- Respiratory Diseases
- Tuberculosis
- Meningitis
- Gastrointestinal Tract Infections
- HPV
- Sexually Transmitted Infections
- Sepsis
- Drug Resistance Diseases
- Others
By End Use
- Hospitals
- Clinics
- Diagnostics Laboratories
- Research Institutes
COMPANIES PROFILED
- Abbott, Danaher Corporation, Bio-Rad Laboratories Inc., bioMerieux SA, F. Hoffmann-La Roche Ltd, Agilent Technologies Inc., Becton, Dickinson and Company, Hologic Inc. (Gen-Probe), Illumina Inc., Grifols S.A., Qiagen
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET: BY PRODUCT
2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product
- 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET: BY
TECHNOLOGY 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Technology
- 5.2. Polymerase Chain Reaction (PCR) Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. In Situ Hybridization Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.5. Chips and Microarrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.6. Mass Spectrometry Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.7. Transcription Mediated Amplification Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET: BY
APPLICATION 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Application
- 6.2. Respiratory Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Tuberculosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Meningitis Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.5. Gastrointestinal Tract Infections Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.6. HPV Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.7. Sexually Transmitted Infections Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.8. Sepsis Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.9. Drug Resistance Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET: BY END USE
2022-2034 (USD MN)
- 7.1. Market Analysis, Insights and Forecast End Use
- 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.4. Diagnostics Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.5. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET: BY REGION
2022-2034 (USD MN)
- 8.1. Regional Outlook
- 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Product
- 8.2.2 By Technology
- 8.2.3 By Application
- 8.2.4 By End Use
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
- 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Product
- 8.3.2 By Technology
- 8.3.3 By Application
- 8.3.4 By End Use
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
- 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Product
- 8.4.2 By Technology
- 8.4.3 By Application
- 8.4.4 By End Use
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
- 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Product
- 8.5.2 By Technology
- 8.5.3 By Application
- 8.5.4 By End Use
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 Rest of Latin America
- 8.6. Middle East & Africa Market Analysis, Insights and Forecast,
2022-2034 (USD MN)
- 8.6.1 By Product
- 8.6.2 By Technology
- 8.6.3 By Application
- 8.6.4 By End Use
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa
Chapter 9. COMPETITIVE LANDSCAPE
- 9.1. Recent Developments
- 9.2. Company Categorization
- 9.3. Supply Chain & Channel Partners (based on availability)
- 9.4. Market Share & Positioning Analysis (based on availability)
- 9.5. Vendor Landscape (based on availability)
- 9.6. Strategy Mapping
Chapter 10. COMPANY PROFILES OF GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS
INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Company Profiles
- 10.2.1 Abbott
- 10.2.2 Danaher Corporation
- 10.2.3 Bio-Rad Laboratories Inc
- 10.2.4 BioMerieux SA
- 10.2.5 F. Hoffmann-La Roche Ltd
- 10.2.6 Agilent Technologies Inc
- 10.2.7 Becton
- 10.2.8 Dickinson And Company
- 10.2.9 Hologic Inc. (Gen-Probe)
- 10.2.10 Illumina Inc
- 10.2.11 Grifols S.A
- 10.2.12 Qiagen
